Dr. Andrew Plump
About Us
Current Events
Past Events
Policy & Reports
Media Coverage
Contact Us
Dr. Andrew Plump
Chief Medical & Scientific Officer
Takeda Pharmaceuticals

Andrew Plump, MD, PhD joined Takeda as Chief Medical and Scientific Officer (CMSO) in 2015. Dr. Plump also serves as a member of the company’s Board of Directors. In this role, he leads Takeda’s global Research & Development organization, where he provides strategic direction and oversight.

Dr. Plump brings an unwavering focus on patients and a deep commitment to innovation and positive change to the healthcare industry. To accelerate Takeda’s R&D successes, he leads an organization focused on people and partnerships, modality diversification, translational medicine and genomics. Dr. Plump led the global R&D organization through a transformation, focusing on three therapeutic areas—gastroenterology, neuroscience and oncology—plus vaccines. Under his leadership, Takeda expanded its collaborative R&D model, forging 75 new partnerships in the last two years. He helped establish an industry-leading partnership with PRA, a global CRO to scale up development capacity and improve operating efficiencies. Prior to Takeda, Dr. Plump served as Senior Vice President, Research & Translational Medicine, Deputy to the President of R&D at Sanofi where he was responsible for global research and translational medicine, across all therapeutic areas.

He also spent more than 10 years at Merck in a Clinical Pharmacology group, working on programs in neurodegeneration, immunology, metabolism and infectious diseases. He ultimately assumed the role of Vice President, Worldwide Cardiovascular (CV) Research Head.

Dr. Plump received his medical degree from the University of California, San Francisco (UCSF), his doctorate in cardiovascular genetics with Dr. Jan Breslow from the Rockefeller University and his bachelor’s degree from the Massachusetts Institute of Technology. He completed a residency in Internal Medicine and a fellowship in Medical Genetics at UCSF. Following his clinical training, Dr. Plump continued his scientific training in neuroscience as a Howard Hughes and Stanley J. Sarnoff postdoctoral fellow, with Dr. Marc Tessier-Lavigne, concurrently assuming faculty responsibilities as an Adjunct Clinical Instructor in the Department of Medical Genetics.

© 2007 - USA India Chamber of Commerce Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us